BinbinWangMD
Anesthesiology • San Francisco, CACritical Care Medicine
Assistant Professor, Anesthesia & Perioperative Care, UCSF School of Medicine
Are you Dr. Wang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
521 Parnassus Ave
Rm C-450
San Francisco, CA 94143Phone+1 415-476-3235
Summary
- Dr. Binbin Wang, MD is a board certified anesthesiologist in San Francisco, California. She is currently licensed to practice medicine in California. She is affiliated with UCSF Medical Center and Kaiser Permanente San Francisco Medical Center.
Education & Training
University of California (San Francisco)Fellowship, Critical Care Medicine (Anesthesiology), 2009 - 2010- University of California (San Francisco)Residency, Anesthesiology, 2006 - 2009
California Pacific Medical CenterInternship, Internal Medicine, 2005 - 2006
Icahn School of Medicine at Mount SinaiClass of 2005
Certifications & Licensure
CA State Medical License 2006 - 2026
American Board of Anesthesiology Anesthesiology- American Board of Anesthesiology Critical Care Medicine
Publications & Presentations
PubMed
- The Association Between Aspartate Transaminase to Alanine Transaminase Ratio and Perioperative Ischemic Stroke in Patients With Diabetes: A Retrospective Cohort Study.Siyuan Liu, Binbin Wang, Libin Ma, Huikai Yang, Min Liu
CNS Neuroscience & Therapeutics. 2025-01-01 - Lipidomics analysis of bone marrow in a mouse model of postmenopausal osteoporosis.Ziqing Zhong, Yongling Chen, Xuelian Ruan, Huilin Xie, Binbin Wang
Journal of Pharmaceutical and Biomedical Analysis. 2024-08-15 - Ultrasonographic Assessment of Gastric Volume in Fasted Patients Undergoing Gastrointestinal Endoscopy Under Sedation.Heng Rong, Weixin Dai, Yinying Qin, Zhikeng Meng, Xia Zou
Therapeutics and Clinical Risk Management. 2023-01-01
Press Mentions
- Resveratrol Attenuates TLR-4 Mediated Inflammation and Elicits Therapeutic Potential in Models of SepsisNovember 2nd, 2020
